Tag: CIRM
CIRM Grants $3.99 Million to Poseida’s P-PSMA101 CAR-T for Prostate Cancer
Poseida Therapeutics Inc., headquartered in San Diego, spun-out of Transposagen Biopharmaceuticals in 2015. The company is translating best-in-class gene engineering technologies into lifesaving cell therapies. This includes developing CAR T-cell immunotherapies for multiple myeloma (phase I), prostate and other...
